Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Clin Orthop Relat Res ; (386): 71-8, 2001 May.
Article in English | MEDLINE | ID: mdl-11347851

ABSTRACT

Although core decompression is one of the more popular procedures for treating avascular necrosis, considerable controversy exists concerning its safety and effectiveness. The current authors review the results of a prospective study of 406 hips in 285 patients treated by one surgeon with core decompression and bone grafting. Patients were followed up for 2 to 14 years. The outcome was determined by the change in the Harris hip score, quantitative radiographic measurements, and need for total hip replacement. These hips were compared with 55 hips in 39 patients treated non-operatively and with historic controls. Five complications occurred after 406 procedures including two fractures that resulted from falls during the first postoperative month. Of the 312 hips in 208 patients with a minimum 2-year followup, 36% of hips (113 hips in 90 patients) required hip replacement at a mean of 29 months: 18 of 65 hips (28%) with Stage I disease; 45 of 133 hips (34%) with Stage II disease; three of 13 hips (23%) with Stage III disease; and 45 of 92 hips (49%) with Stage IV disease. Before femoral head collapse (Stages I and II combined) hip replacement was performed in 10 of 77 hips (14%) with small lesions (A), 33 of 68 hips (48%) with intermediate lesions (B), and 20 of 48 hips (42%) with large lesions (C). Results as determined by changes in Harris hip scores and radiographic progression were similar. Patients who underwent core decompression and bone grafting have a very low complication rate. In patients treated before femoral head collapse, the outcome is significantly better than in patients who received symptomatic treatment. The results are correlated with the stage and the size of the necrotic lesion.


Subject(s)
Bone Transplantation/methods , Decompression, Surgical/methods , Femur Head Necrosis/surgery , Adult , Aged , Electric Stimulation , Female , Femur Head Necrosis/diagnosis , Femur Head Necrosis/rehabilitation , Follow-Up Studies , Graft Survival , Humans , Male , Middle Aged , Sensitivity and Specificity , Severity of Illness Index , Treatment Outcome
2.
J Virol ; 75(10): 4907-11, 2001 May.
Article in English | MEDLINE | ID: mdl-11312363

ABSTRACT

We longitudinally measured T-cell receptor transcript frequencies of human immunodeficiency virus type 1 (HIV-1) specific cytotoxic T lymphocytes (CTL) in an individual with rapidly progressive disease and high levels of viremia. CTL clones elicited during acute HIV-1 infection were present at the time of death, despite absent functional CTL responses, arguing against clonal deletion as a mechanism for the decline of CTL responses observed during HIV-1 infection.


Subject(s)
HIV Infections/immunology , HIV-1/immunology , Receptors, Antigen, T-Cell, alpha-beta/genetics , T-Lymphocytes, Cytotoxic/immunology , Chronic Disease , Clone Cells , Disease Progression , HIV Infections/blood , HIV Infections/virology , Humans , Longitudinal Studies , Receptors, Antigen, T-Cell, alpha-beta/immunology , Time Factors
3.
Nat Biotechnol ; 18(7): 729-34, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10888839

ABSTRACT

Biocompatible inorganic matrices have been used to enhance bone repair by integrating with endogenous bone architecture. Hypothesizing that a three-dimensional framework might support reconstruction of other tissues as well, we assessed the capacity of a tantalum-coated carbon matrix to support reconstitution of functioning thymic tissue. We engineered a thymic organoid by seeding matrices with murine thymic stroma. Co-culture of human bone marrow-derived hematopoietic progenitor cells within this xenogeneic environment generated mature functional T cells within 14 days. The proportionate T-cell yield from this system was highly reproducible, generating over 70% CD3+ T cells from either AC133+ or CD34+ progenitor cells. Cultured T cells expressed a high level of T-cell receptor excision circles (TREC), demonstrating de novo T lymphopoiesis, and function of fully mature T cells. This system not only facilitates analysis of the T-lymphopoietic potential of progenitor cell populations; it also permits ex vivo genesis of T cells for possible applications in treatment of immunodeficiency.


Subject(s)
Artificial Organs , Organoids/physiology , T-Lymphocytes/physiology , Thymus Gland/physiology , AC133 Antigen , Animals , Antigens, CD , Antigens, CD34/biosynthesis , Bone Marrow Cells/cytology , Carbon/metabolism , Coated Materials, Biocompatible , Coculture Techniques , Culture Techniques/methods , Flow Cytometry , Glycoproteins/metabolism , HIV-1/metabolism , Hematopoietic Stem Cells/cytology , Humans , Immunophenotyping , Mice , Mice, Inbred C57BL , Microscopy, Electron, Scanning , Organoids/ultrastructure , Peptides/metabolism , Polymerase Chain Reaction , T-Lymphocytes/cytology , Thymus Gland/cytology , Thymus Gland/ultrastructure , Time Factors
4.
J Virol ; 74(12): 5679-90, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10823876

ABSTRACT

Cytotoxic T-lymphocyte (CTL) activity plays a central role in control of viral replication and in determining outcome in cases of human immunodeficiency virus type 1 (HIV-1) infection. Incorporation of important CTL epitope sequences into candidate vaccines is, therefore, vital. Most CTL studies have focused upon small numbers of adult Caucasoid subjects infected with clade-B virus, whereas the global epidemic is most severe in sub-Saharan African populations and predominantly involves clade-C infection in both adults and children. In this study, sensitive enzyme-linked immunospot (elispot) assays have been utilized to identify the dominant Gag-specific CTL epitopes targeted by adults and children infected with clade-B or -C virus. Cohorts evaluated included 44 B-clade-infected Caucasoid American and African American adults and children and 37 C-clade-infected African adults and children from Durban, South Africa. The results show that 3 out of 46 peptides spanning p17(Gag) and p24(Gag) sequences tested contain two-thirds of the dominant Gag-specific epitopes, irrespective of the clade, ethnicity, or age group studied. However, there were distinctive differences between the dominant responses made by Caucasoids and Africans. Dominant responses in Caucasoids were more often within p17(Gag) peptide residues 16 to 30 (38 versus 12%; P < 0.01), while p24(Gag) peptide residues 41 to 60 contained the dominant Gag epitope more often in the African subjects tested (39 versus 4%; P < 0.005). Within this 20-mer p24(Gag), an epitope presented by both B42 and B81 is defined which represents the dominant Gag response in >30% of the total infected population in Durban. This epitope is closely homologous with dominant HIV-2 and simian immunodeficiency virus Gag-specific CTL epitopes. The fine focusing of dominant CTL responses to these few regions of high immunogenicity is of significance to vaccine design.


Subject(s)
Black People , Gene Products, gag/immunology , HIV Infections/immunology , Immunodominant Epitopes/immunology , T-Lymphocytes, Cytotoxic/immunology , Viral Proteins , White People , Adult , Aging/immunology , Amino Acid Sequence , Amino Acid Substitution , Boston/epidemiology , Cells, Cultured , Child , Cohort Studies , Epitopes, T-Lymphocyte/chemistry , Epitopes, T-Lymphocyte/immunology , Gene Products, gag/chemistry , HIV Antigens/chemistry , HIV Antigens/immunology , HIV Core Protein p24/chemistry , HIV Core Protein p24/immunology , HIV Infections/ethnology , HIV-1/classification , HIV-1/immunology , Humans , Immunodominant Epitopes/chemistry , Molecular Sequence Data , Peptide Fragments/chemistry , Peptide Fragments/immunology , South Africa/epidemiology , gag Gene Products, Human Immunodeficiency Virus
5.
J Immunol ; 162(8): 4796-800, 1999 Apr 15.
Article in English | MEDLINE | ID: mdl-10202022

ABSTRACT

To address the issue of clonal exhaustion in humans, we monitored HLA class I-restricted, epitope-specific CTL responses in an in utero HIV-1-infected infant from 3 mo through 5 years of age. Serial functional CTL precursor assays demonstrated persistent, vigorous, and broadly directed HIV-1 specific CTL activity with a dominant response against an epitope in HIV-1 Gag-p17 (SLYNTVATL, aa 77-85). A clonal CTL response directed against the immunodominant, HLA-A*0201-restricted epitope was found to persist over the entire observation period, as shown by TCR analysis of cDNA libraries generated from PBMC. The analysis of autologous viral sequences did not reveal any escape mutations within the targeted epitope, and viral load measurement indicated ongoing viral replication. Furthermore, inhibition of viral replication assays indicated that the epitope was properly processed from autologous viral protein. These data demonstrate that persistent exposure to high levels of viral Ag does not necessarily lead to clonal exhaustion and that epitope-specific clonal CTL responses induced within the first weeks of life can persist for years without inducing detectable viral escape variants.


Subject(s)
Epitopes, T-Lymphocyte/immunology , HIV Infections/immunology , HIV-1/immunology , Pregnancy Complications, Infectious/immunology , T-Lymphocytes, Cytotoxic/immunology , T-Lymphocytes, Cytotoxic/virology , Viral Load , Child, Preschool , Clone Cells/immunology , Clone Cells/virology , Cytotoxicity Tests, Immunologic , Female , Gene Products, gag/immunology , Gene Products, gag/isolation & purification , HIV Infections/transmission , HIV Infections/virology , HIV-1/physiology , Humans , Infant , Lymphocyte Count , Pregnancy , Pregnancy Complications, Infectious/virology , Puerperal Infection/immunology , Puerperal Infection/virology , Stem Cells/immunology , Stem Cells/virology , Virus Latency/immunology , Virus Replication/immunology
6.
J Clin Invest ; 101(11): 2559-66, 1998 Jun 01.
Article in English | MEDLINE | ID: mdl-9616227

ABSTRACT

Despite detailed analysis of the HIV-1-specific cytotoxic T lymphocyte response by various groups, its relation to viral load and viral sequence variation remains controversial. We analyzed HLA-A*0201 restricted cytotoxic T lymphocyte responses in 17 HIV-1-infected individuals with viral loads ranging from < 400 to 221,000 HIV RNA molecules per milliliter of plasma. In 13 out of 17 infected subjects, CTL responses against the SLYNTVATL epitope (p17 Gag; aa 77-85) were detectable, whereas two other HLA-A*0201 restricted epitopes (ILKEPVHGV, IV9; and VIYQYMDDL, VL9) were only recognized by six and five individuals out of 17 individuals tested, respectively. Naturally occurring variants of the SL9 epitope were tested for binding to HLA-A*0201 and for recognition by specific T cell clones generated from five individuals. Although these variants were widely recognized, they differed by up to 10,000-fold in terms of variant peptide concentrations required for lysis of target cells. A comparison of viral sequences derived from 10 HLA-A*0201-positive individuals to sequences obtained from 11 HLA-A*0201-negative individuals demonstrated only weak evidence for immune selective pressure and thus question the in vivo efficacy of immunodominant CTL responses present during chronic HIV-1 infection.


Subject(s)
Acquired Immunodeficiency Syndrome/immunology , HIV-1 , HLA-A Antigens/physiology , T-Lymphocytes, Cytotoxic/immunology , Chronic Disease , Epitopes , Hematopoietic Stem Cells/immunology , Humans
7.
J Exp Med ; 183(4): 1669-79, 1996 Apr 01.
Article in English | MEDLINE | ID: mdl-8666925

ABSTRACT

Numerous virus-specific, class I-restricted cytotoxic T lymphocyte (CTL) epitopes have been identified, yet little information is available regarding the specificity of the CTL response in persons of the same human histocompatibility leukocyte antigen (HLA) type. In this study, the human immunodeficiency virus (HIV) 1 envelope-specific CTL response was evaluated in five HLA-B14-positive persons. CTL responses specific for a previously described nine-amino acid epitope in gp41 (aa 584-592, ERYLKDQQL) could be identified in all subjects, and CTL clones specific for this epitope could be isolated from four persons. Despite heterogeneous T cell receptor usage, the fine specificity of the clones was similar, as defined by recognition of alanine-substituted peptides as well as peptides representing natural HIV-1 sequence variants. Correlation with in vivo virus sequences revealed that the dominant species in two of the subjects represented poorly recognized variants, with a K-->Q substitution at amino acid 588, whereas no variants were observed in the other two subjects. Although clonal type-specific responses to these dominant variants could be identified, the magnitude of these responses remained small, and the dominant CTL response was directed at the minor in vivo variant. These studies indicate that despite similar epitope-specific immunologic pressure in persons of the same HLA type, the in vivo quasispecies may differ, and that the major in vivo immune response to a given CTL epitope can be directed at a minor variant.


Subject(s)
HIV Envelope Protein gp41/immunology , HIV Infections/immunology , HIV-1/immunology , HLA-B Antigens/immunology , Peptide Fragments/immunology , Receptors, Antigen, T-Cell, alpha-beta/genetics , T-Lymphocytes, Cytotoxic/immunology , Amino Acid Sequence , Antigens, Viral/genetics , Antigens, Viral/immunology , Base Sequence , Clone Cells , Genetic Variation , HIV Envelope Protein gp41/genetics , HIV-1/genetics , HLA-B14 Antigen , Histocompatibility Testing , Humans , Immunodominant Epitopes/genetics , Immunodominant Epitopes/immunology , Male , Molecular Sequence Data , Peptide Fragments/genetics , Sequence Analysis, DNA , Sequence Homology , Species Specificity , T-Lymphocytes, Cytotoxic/cytology
SELECTION OF CITATIONS
SEARCH DETAIL
...